Placental Protein 13 Administration to Pregnant Rats Lowers Blood Pressure and Augments Fetal Growth and Venous Remodeling. 2016

Sveinbjorn Gizurarson, and Elisabet Run Sigurdardottir, and Hamutal Meiri, and Berthold Huppertz, and Marei Sammar, and Adi Sharabi-Nov, and Maurizio Mandalá, and George Osol
Faculty of Pharmaceutical Sciences, School of Health Science, University of Iceland, Reykjavik, Iceland.

Reduced first-trimester concentrations of placental protein 13 (PP13) are associated with subsequent development of preeclampsia, a major pregnancy disorder. We previously showed that PP13 has a vasodilatory effect, reduces blood pressure and augments expansive remodeling of the uteroplacental vasculature in pregnant rats. In this study, slow-release osmotic pumps were implanted in gravid rats (on day 8) to provide 1 week of PP13 supplementation. Treatment was associated with a reversible blood pressure reduction that returned to normal on day 15. In addition, PP13 caused venous expansion that is larger in the venous branches closer to the placenta. Then, it increased placental and pup weights. Similar administration of a truncated PP13 variant (DelT221) that is unable to bind carbohydrates (a rare spontaneous mutation associated with a high frequency of severe early preeclampsia among Blacks in South Africa) produced a hypotensive effect similar to the full-length molecule, but without venous remodeling and increased placental and pup weights. These results indicate the importance of PP13 carbohydrate binding for inducing vascular remodeling and improving reproductive outcome. Future studies are needed to determine whether beneficial effects would be evident in animal models of preeclampsia or in women predisposed to the development of preeclampsia.

UI MeSH Term Description Entries
D008098 Litter Size The number of offspring produced at one birth by a viviparous animal. Litter Sizes,Size, Litter,Sizes, Litter
D010920 Placenta A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES). Placentoma, Normal,Placentome,Placentas,Placentomes
D011225 Pre-Eclampsia A complication of PREGNANCY, characterized by a complex of symptoms including maternal HYPERTENSION and PROTEINURIA with or without pathological EDEMA. Symptoms may range between mild and severe. Pre-eclampsia usually occurs after the 20th week of gestation, but may develop before this time in the presence of trophoblastic disease. Toxemias, Pregnancy,EPH Complex,EPH Gestosis,EPH Toxemias,Edema-Proteinuria-Hypertension Gestosis,Gestosis, EPH,Hypertension-Edema-Proteinuria Gestosis,Preeclampsia,Preeclampsia Eclampsia 1,Pregnancy Toxemias,Proteinuria-Edema-Hypertension Gestosis,Toxemia Of Pregnancy,1, Preeclampsia Eclampsia,1s, Preeclampsia Eclampsia,EPH Toxemia,Eclampsia 1, Preeclampsia,Eclampsia 1s, Preeclampsia,Edema Proteinuria Hypertension Gestosis,Gestosis, Edema-Proteinuria-Hypertension,Gestosis, Hypertension-Edema-Proteinuria,Gestosis, Proteinuria-Edema-Hypertension,Hypertension Edema Proteinuria Gestosis,Of Pregnancies, Toxemia,Of Pregnancy, Toxemia,Pre Eclampsia,Preeclampsia Eclampsia 1s,Pregnancies, Toxemia Of,Pregnancy Toxemia,Pregnancy, Toxemia Of,Proteinuria Edema Hypertension Gestosis,Toxemia Of Pregnancies,Toxemia, EPH,Toxemia, Pregnancy,Toxemias, EPH
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011257 Pregnancy Proteins Proteins produced by organs of the mother or the PLACENTA during PREGNANCY. These proteins may be pregnancy-specific (present only during pregnancy) or pregnancy-associated (present during pregnancy or under other conditions such as hormone therapy or certain malignancies.) Placental Proteins,Proteins, Placental,Proteins, Pregnancy
D001724 Birth Weight The mass or quantity of heaviness of an individual at BIRTH. It is expressed by units of pounds or kilograms. Birthweight,Birth Weights,Birthweights,Weight, Birth,Weights, Birth
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Sveinbjorn Gizurarson, and Elisabet Run Sigurdardottir, and Hamutal Meiri, and Berthold Huppertz, and Marei Sammar, and Adi Sharabi-Nov, and Maurizio Mandalá, and George Osol
November 1993, The Journal of endocrinology,
Sveinbjorn Gizurarson, and Elisabet Run Sigurdardottir, and Hamutal Meiri, and Berthold Huppertz, and Marei Sammar, and Adi Sharabi-Nov, and Maurizio Mandalá, and George Osol
July 1981, Experientia,
Sveinbjorn Gizurarson, and Elisabet Run Sigurdardottir, and Hamutal Meiri, and Berthold Huppertz, and Marei Sammar, and Adi Sharabi-Nov, and Maurizio Mandalá, and George Osol
November 2020, Journal of hypertension,
Sveinbjorn Gizurarson, and Elisabet Run Sigurdardottir, and Hamutal Meiri, and Berthold Huppertz, and Marei Sammar, and Adi Sharabi-Nov, and Maurizio Mandalá, and George Osol
November 2012, Placenta,
Sveinbjorn Gizurarson, and Elisabet Run Sigurdardottir, and Hamutal Meiri, and Berthold Huppertz, and Marei Sammar, and Adi Sharabi-Nov, and Maurizio Mandalá, and George Osol
April 2005, Journal of hypertension,
Sveinbjorn Gizurarson, and Elisabet Run Sigurdardottir, and Hamutal Meiri, and Berthold Huppertz, and Marei Sammar, and Adi Sharabi-Nov, and Maurizio Mandalá, and George Osol
January 2013, Hypertension (Dallas, Tex. : 1979),
Sveinbjorn Gizurarson, and Elisabet Run Sigurdardottir, and Hamutal Meiri, and Berthold Huppertz, and Marei Sammar, and Adi Sharabi-Nov, and Maurizio Mandalá, and George Osol
December 1988, Pediatric research,
Sveinbjorn Gizurarson, and Elisabet Run Sigurdardottir, and Hamutal Meiri, and Berthold Huppertz, and Marei Sammar, and Adi Sharabi-Nov, and Maurizio Mandalá, and George Osol
November 2006, DukeMedicine healthnews,
Sveinbjorn Gizurarson, and Elisabet Run Sigurdardottir, and Hamutal Meiri, and Berthold Huppertz, and Marei Sammar, and Adi Sharabi-Nov, and Maurizio Mandalá, and George Osol
March 2012, Nature reviews. Endocrinology,
Sveinbjorn Gizurarson, and Elisabet Run Sigurdardottir, and Hamutal Meiri, and Berthold Huppertz, and Marei Sammar, and Adi Sharabi-Nov, and Maurizio Mandalá, and George Osol
January 2022, Frontiers in physiology,
Copied contents to your clipboard!